about
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surfaceRituximab Treatment in a Patient with Active Graves' Orbitopathy and Psoriasis.Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye DiseaseThe Efficacy of Rituximab Combined with 131I for Ophthalmic Outcomes of Graves' Ophthalmopathy Patients.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in the management of thyroid eye disease
@en
Advances in the management of thyroid eye disease.
@nl
type
label
Advances in the management of thyroid eye disease
@en
Advances in the management of thyroid eye disease.
@nl
prefLabel
Advances in the management of thyroid eye disease
@en
Advances in the management of thyroid eye disease.
@nl
P2093
P2860
P1476
Advances in the management of thyroid eye disease
@en
P2093
César A Briceño
Raymond S Douglas
Shivani Gupta
P2860
P304
P356
10.1097/IIO.0B013E318293C44E
P577
2013-01-01T00:00:00Z